A cluster of translocation breakpoints in 2q37 is associated with overexpression of NPPC in patients with a similar overgrowth phenotype

Overexpression of the C‐type natriuretic peptide, encoded by the NPPC gene in 2q37.1, was recently reported in a patient presenting an overgrowth phenotype and a balanced t(2;7)(q37.1;q21.3) translocation. We present clinical, cytogenetic, and molecular data from two additional patients carrying balanced translocations involving the same 2q37.1 chromosome band and chromosomes 8 and 13, respectively. The clinical phenotype of these patients is very similar to the first patient described. In addition to the overgrowth syndrome, there is evidence of generalized cartilage dysplasia. In these two new cases, we found overexpression of NPPC, confirming that this unusual overgrowth phenotype in humans is due to the overexpression of this gene. The involvement of three different chromosomes and a cluster of breakpoints around the NPPC gene suggests that the overexpression of this gene in translocation patients could be due to its separation from a negative regulatory element located on chromosome 2, which would constitute a previously undescribed mutational mechanism. Hum Mutat 28(12),1183–1188, 2007. © 2007 Wiley‐Liss, Inc.

[1]  R. Ravazzolo,et al.  Overexpression of the C‐type natriuretic peptide (CNP) is associated with overgrowth and bone anomalies in an individual with balanced t(2;7) translocation , 2007, Human mutation.

[2]  F. Glorieux,et al.  Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans , 2007, Human mutation.

[3]  P. Stankiewicz,et al.  Position effects due to chromosome breakpoints that map ∼900 Kb upstream and ∼1.3 Mb downstream of SOX9 in two patients with campomelic dysplasia , 2005 .

[4]  J. Mulvihill,et al.  Chromosome 2q terminal deletion: Report of 6 new patients and review of phenotype‐breakpoint correlations in 66 individuals , 2004, American journal of medical genetics. Part A.

[5]  K. Nakao,et al.  Dwarfism and early death in mice lacking C-type natriuretic peptide , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[6]  J. Rossert,et al.  Regulation of type I collagen genes expression. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[7]  N. Tamura,et al.  Natriuretic Peptide Regulation of Endochondral Ossification , 1998, The Journal of Biological Chemistry.

[8]  F. Roudot-thoraval,et al.  Renal and vascular effects of C-type and atrial natriuretic peptides in humans. , 1997, American journal of physiology. Regulatory, integrative and comparative physiology.

[9]  D. Ledbetter,et al.  A revision of the lissencephaly and Miller-Dieker syndrome critical regions in chromosome 17p13.3. , 1997, Human molecular genetics.

[10]  N. Minamino,et al.  C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain. , 1990, Biochemical and biophysical research communications.

[11]  M. Mancini,et al.  Characterization of a recurrent translocation t(2;3)(p15–22;q26) occurring in acute myeloid leukaemia , 2006, Leukemia.

[12]  P. Stankiewicz,et al.  Position effects due to chromosome breakpoints that map approximately 900 Kb upstream and approximately 1.3 Mb downstream of SOX9 in two patients with campomelic dysplasia. , 2005, American journal of human genetics.

[13]  D. Kleinjan,et al.  Long-range control of gene expression: emerging mechanisms and disruption in disease. , 2005, American journal of human genetics.

[14]  K. Nakao,et al.  Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway , 2004, Nature Medicine.

[15]  明宏 八十田.  Natriuretic peptide regulation of endochondral ossification : evidence for possible roles of the C-type natriuretic peptide/guanylyl cyclase-B pathway , 1999 .